|
PureBytes Links
Trading Reference Links
|
Does this mean that MSFT would have to show by clinical scientific study
that their software does what it is supposed to?
[GRIN]
Jim
> -----Original Message-----
> From: Jim Allen [SMTP:jallen7@xxxxxxxxxxxxx]
> Sent: Tuesday, May 11, 1999 9:48 AM
> To: Omega Mail List
> Subject: Re: CFTC Case Update
>
[Money, James L] SNIP
>
> What is really needed is an FDA type approach, where, before marketing a
> system,
> the vendor has to show by clinical scientific studies that not only does
> his system
> do no harm, it actually has a valid chance of doing what it is
> supposed/claimed to
> do. Omega could use this sort of discipline.
>
> Jim Allen
>
> Sentinel Trading wrote:
>
> > [Money, James L] SNIP
>
|